BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

Description

This post-market study is being conducted to generate safety and performance data on the BD Prevue(TM) II Peripheral Vascular Access System with Cue(TM) Needle Tracking Technology. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.

Conditions

BD Prevue II for Peripheral Intravenous Catheter Placement

Talk to us

Study Overview

On this page

Study Details

Study overview

This post-market study is being conducted to generate safety and performance data on the BD Prevue(TM) II Peripheral Vascular Access System with Cue(TM) Needle Tracking Technology. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

Condition
BD Prevue II for Peripheral Intravenous Catheter Placement
Intervention / Treatment

-

Contacts and Locations

Brooklyn

Brookdale University Hospital & Medical Center, Brooklyn, New York, United States, 11212

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 1 years, or older
  • * A patient who is a candidate for an ultrasound-guided peripheral intravenous catheter (midline catheters included) placement procedure using BD PrevueTM II Peripheral Vascular Access System with CueTM Needle Tracking Technology as assessed per their clinician(s)
  • * Able and willing to provide informed consent or legal authorized representative (LAR) authorized to give consent on behalf of the subject
  • * Any patient in whom ultrasound procedure might interfere with medical care or create undue hardship
  • * Known, or suspected, allergy to materials contained in the BD PrevueTM II Peripheral Vascular Access System with CueTM Needle Tracking Technology or accessories that may come in contact with the patient
  • * Localized skin, tissue, or other clinical factors that would prevent completion of the ultrasound procedure
  • * Previous medical history that would prevent completion of the ultrasound procedure

Ages Eligible for Study

1 Year to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Becton, Dickinson and Company,

Study Record Dates

2025-08